Beyond the gut - Atypical presentation of Salmonella spp. infection

1 Kam JC, Abdul-Jawad S, Modi C, Abdeen Y, Asslo F, DePasquale JR, et al. Pleural Empyema due to Group D Salmonella. Case Rep Gastrointest Med. 2012 Sep 29;2012:e524561. Search in Google Scholar

2 Xaplanteri P, Assimakopoulos SF, Karachalios K, Siagris D, Lekkou A, Anastassiou ED, et al. Pleural empyema due to Salmonella enterica serovar Enteritidis in an immunocompetent elderly patient: a case report. JMM Case Rep. 2016 Aug;3(4):e005051. Search in Google Scholar

3 Rim MS, Park CM, Ko KH, Lim SC, Park KO. Pleural Empyema Due To Salmonella: A Case Report. Korean J Intern Med. 2000 Jul;15(2):138–41. Search in Google Scholar

4 Rôlo Silvestre C, Nunes A, Cordeiro RJ, Eusébio J, André N, Falcão T, et al. Salmonella empyema an unusual infection – A case report. IDCases. 2021 Jan 1;24:e01096. Search in Google Scholar

5 Bretzing D, Lat T, Shakespeare A, Lee M, Surani S, Ghamande S. Nontyphi Salmonella Empyema with Bronchopleural Fistula in a Patient with Human Immunodeficiency Virus. Case Rep Pulmonol. 2018 Jun 12;2018:4761725. Search in Google Scholar

6 Nath G, Maurya P, Gulati AK. ERIC PCR and RAPD based fingerprinting of Salmonella Typhi strains isolated over a period of two decades. Infect Genet Evol. 2010 May 1;10(4):530–6. Search in Google Scholar

7 Lussana F, Cattaneo M, Rambaldi A, Squizzato A. Ruxolitinib-associated infections: A systematic review and meta-analysis. Am J Hematol. 2018;93(3):339–47. Search in Google Scholar

8 McLornan DP, Khan AA, Harrison CN. Immunological Consequences of JAK Inhibition: Friend or Foe? Curr Hematol Malig Rep. 2015 Dec 1;10(4):370–9. Search in Google Scholar

9 Quintás-Cardama A, Kantarjian H, Cortes J, Verstovsek S. Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond. Nat Rev Drug Discov. 2011 Feb;10(2):127–40. Search in Google Scholar

10 Schönberg K, Rudolph J, Vonnahme M, Parampalli Yajnanarayana S, Cornez I, Hejazi M, et al. JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms. Cancer Res. 2015 Jun 1;75(11):2187–99. Search in Google Scholar

11 Heine A, Brossart P, Wolf D. Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? Blood. 2013 Nov 28;122(23):3843–4. Search in Google Scholar

12 Awang MS, Bustami Y, Hamzah HH, Zambry NS, Najib MA, Khalid MF, et al. Advancement in Salmonella Detection Methods: From Conventional to Electrochemical-Based Sensing Detection. Biosensors. 2021 Sep 18;11(9):346. Search in Google Scholar

13 Michael GB, Butaye P, Cloeckaert A, Schwarz S. Genes and mutations conferring antimicrobial resistance in Salmonella: an update. Microbes Infect. 2006 Jun 1;8(7):1898–914. Search in Google Scholar

14 WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet]. Available from: https://www.who.int/publications-detail-redirect/9789240093461 Search in Google Scholar